{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 0,
        "end": 12
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 47,
        "end": 56
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 143,
        "end": 147
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 143,
        "end": 179
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 182,
        "end": 187
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "15998902_8",
  "text": "Temsirolimus peak concentration ( Cmax ) , and sirolimus Cmax and area under the concentration-time curve were decreased in patients receiving p450 enzyme-inducing anticonvulsants ( EIACs ) by 73 % , 47 % , and 50 % , respectively , but were still within the therapeutic range of preclinical models ."
}
